An update from Gritstone Oncology Inc (GRTS) is now available.
Steve Krognes has decided not to seek re-election to Gritstone bio, Inc.’s Board of Directors during the forthcoming stockholders’ meeting, with no disagreements prompting his departure. Stephen W. Webster has been appointed in his stead, bringing his expertise to the Board’s Audit and Compensation Committees and poised to become the Audit Committee Chair after Krognes’s term ends. Webster’s directorship includes a financial compensation package and an option to purchase company stock, underlining the company’s commitment to aligning board members’ interests with those of its shareholders.
For an in-depth examination of GRTS stock, go to TipRanks’ Stock Analysis page.
